Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06051695 2026-05-26

EVEREST-2

Phase 1/2 Recruiting

474 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT07446855 2026-05-26

PARTHENON

Phase 1/2 Recruiting

180 enrolled

Other solid neoplasm

Solid Tumours

NCT05277168 2026-05-22

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Phase 1/2 Recruiting

83 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06656390 2026-05-22

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

202 enrolled

Other solid neoplasm

Advanced Cancer

NCT06977737 2026-05-22

ATTEST

Phase 1/2 Recruiting

72 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT07192432 2026-05-22

SENTRY-HER2

Phase 1/2 Recruiting

27 enrolled

Other solid neoplasm

HER2 Expressing Solid Tumors

NCT07205718 2026-05-22

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Phase 1/2 Recruiting

223 enrolled

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT06598371 2026-05-20

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Phase 1/2 Recruiting

141 enrolled

Other solid neoplasm

Select Advanced Solid Tumors

NCT07459998 2026-05-18

SKB103 for Injection in Advanced Solid Tumors

Phase 1/2 Recruiting

277 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05170958 2026-05-15

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Phase 1/2 Recruiting

396 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07160725 2026-05-15

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

315 enrolled

Other solid neoplasm

Solid Tumours

NCT07589530 2026-05-15

SOLID-NK

Phase 1/2 Recruiting

60 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07436728 2026-05-14

A Study of TAK-505 in Adults With Solid Tumors

Phase 1/2 Recruiting

151 enrolled

Other solid neoplasm

Malignant Solid Tumors

NCT07455734 2026-05-14

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

Phase 1/2 Recruiting

533 enrolled

Other solid neoplasm

Advanced Solid Tumor Cancer

NCT05036226 2026-05-13

COAST

Phase 1/2 Recruiting

76 enrolled

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT07266428 2026-05-13

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

170 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06130553 2026-05-11

PRIMROSE

Phase 1/2 Recruiting

334 enrolled

Other solid neoplasm

Advanced Solid Tumors That Are MTAP Deficient

NCT06474455 2026-05-11

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

156 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06725758 2026-05-08

TEADES

Phase 1/2 Recruiting

315 enrolled

Other solid neoplasm

Solid Tumours

NCT06885281 2026-05-08

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

112 enrolled

Other solid neoplasm

Solid Tumors

NCT07380386 2026-05-08

SKB105 for Injection in Advanced Solid Tumors

Phase 1/2 Recruiting

256 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06819735 2026-05-06

DOMISOL

Phase 1/2 Recruiting

125 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05038150 2026-05-05

Study of SGN1 in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

70 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05103345 2026-05-05

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

70 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06214143 2026-05-05

A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

68 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06795412 2026-05-04

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Phase 1/2 Recruiting

220 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07563738 2026-05-04

TEADCO

Phase 1/2 Recruiting

229 enrolled

GastrointestinalOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Pancreatic Neoplasms

NCT07298772 2026-05-01

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

Phase 1/2 Recruiting

198 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07300943 2026-05-01

Study in Advanced Solid Tumor Patients

Phase 1/2 Recruiting

306 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06710756 2026-04-30

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase 1/2 Recruiting

112 enrolled

GastrointestinalGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Mesothelioma, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT06833008 2026-04-30

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Phase 1/2 Recruiting

85 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07556276 2026-04-29

Study of CMTS1215 Injection in Patients With Solid Tumors

Phase 1/2 Recruiting

20 enrolled

Other solid neoplasm

Solid Tumor

NCT05451602 2026-04-28

HEC169096 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

456 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07258121 2026-04-28

Study of ZGGS34 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

400 enrolled

Other solid neoplasm

Solid Tumor

NCT06144671 2026-04-27

GT201 Injection For The Treatment Of Advanced Solid Tumors

Phase 1/2 Recruiting

18 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04939610 2026-04-23

LuMIERE

Phase 1/2 Recruiting

222 enrolled

Other solid neoplasm

Solid Tumor

NCT07136779 2026-04-22

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

Phase 1/2 Recruiting

310 enrolled

Other solid neoplasm

Participants With Advanced Solid Tumor Malignancies

NCT07299747 2026-04-22

Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors

Phase 1/2 Recruiting

255 enrolled

Other solid neoplasm

Participants With Advanced Solid Tumor Malignancies

NCT05732831 2026-04-21

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Phase 1/2 Recruiting

225 enrolled

GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Sarcoma, Cholangiocarcinoma, Neurofibrosarcoma

NCT04219254 2026-04-15

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

197 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06741644 2026-04-15

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

660 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06362369 2026-04-13

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Phase 1/2 Recruiting

126 enrolled

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Turcot syndrome, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms

NCT07326488 2026-04-13

A Study of MHB009C in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

200 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT04626635 2026-04-09

COMBINE-EGFR-1

Phase 1/2 Recruiting

933 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06635785 2026-04-09

BiPAVE-001

Phase 1/2 Recruiting

387 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07192107 2026-04-09

A Study of MHB042C in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

200 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

Clinical Trials

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

RAINFOL-01

EVEREST-2

PARTHENON

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

ATTEST

SENTRY-HER2

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

SKB103 for Injection in Advanced Solid Tumors

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

SOLID-NK

A Study of TAK-505 in Adults With Solid Tumors

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

COAST

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

PRIMROSE

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

TEADES

A Study of ZL-1310 in Participants With Selected Solid Tumors

SKB105 for Injection in Advanced Solid Tumors

DOMISOL

Study of SGN1 in Patients With Advanced Solid Tumor

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

TEADCO

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

Study in Advanced Solid Tumor Patients

Lead-212 PSV359 Therapy for Patients With Solid Tumors

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Study of CMTS1215 Injection in Patients With Solid Tumors

HEC169096 in Participants With Advanced Solid Tumors

Study of ZGGS34 in Participants With Advanced Solid Tumors

GT201 Injection For The Treatment Of Advanced Solid Tumors

LuMIERE

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

A Study of MHB009C in Patients With Advanced Solid Tumors

COMBINE-EGFR-1

BiPAVE-001

A Study of MHB042C in Patients With Advanced Solid Tumors